CUBE vs NXTC · P/E 25, rev $1.07B vs $11.5M cap
CubeSmart (CUBE) versus NextCure Inc (NXTC) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
NextCure Inc (NXTC) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
NXTC does not have a complete income-statement cache yet.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. NXTC currently screens at market cap $11.5M.
Not investment advice. Open the CUBE and NXTC stock pages for the full models.
Not investment advice.